MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Association between severity of freezing of gait and turning characteristics in Parkinson’s disease

    SM. Cheon, JW. Kim (BUSAN, Republic of Korea)

    Objective: To investigate the turning characteristics of people with Parkinson’s disease (PD) with freezing of gait (FoG) according to the turning direction. Background: For people…
  • 2023 International Congress

    The induction of mitochondrial damage by alpha synuclein In Parkinson’s disease.

    B. Adebisi (osogbo, Nigeria)

    Objective: Alpha synuclein aggregation have been indicted in the process of neuronal cell loss in Parkinson's disease; however, there have been several hypothesis to explain…
  • 2023 International Congress

    Efficacy and safety of adjunctive oral therapy in Parkinson’s disease with motor complications: a systematic review and network meta-analysis

    V. Sisodia, L. Dubbeld, RMA. de Bie, GS. Duarte, J. Costa, JM. Dijk (Amsterdam, Netherlands)

    Objective: To review the evidence and compare the efficacy and safety of catechol-O-methyltransferase inhibitors (COMT-Is), dopamine agonists (DAs) and monoamine-oxidase B inhibitors (MAOB-Is) as adjunctive…
  • 2023 International Congress

    Microstructural abnormalities of the dentato-rubro thalamo-cortical tract in tremor dominant PD and ET plus syndrome: A DTI, NODDI and free water-based analysis

    S. Prasad, A. Rajan, R. Bharath, P. Pal, J. Saini (Bengaluru, India)

    Objective: To evaluate microstructural integrity of the dentato-rubro thalamo-cortical tract (DRTT) in tremor dominant Parkinson’s disease (TDPD) and ET plus (ETP) syndrome using a multimodal…
  • 2023 International Congress

    Disease progression of data-driven subtypes of Parkinson Disease (PD): 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

    X. Deng, ES. Saffari, SN. Ng, NC. Chia, XY. Choi, D. Heng, XB. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, EK. Tan, LT. Tan (Singapore, Singapore)

    Objective: To evaluate the non-motor symptom(NMS), motor and cognition progression among the Parkinson Disease (PD) clusters derived from data-driven approach. Background: Data-driven PD subtypes were…
  • 2023 International Congress

    Disruption of Locus Coeruleus-Related Functional Networks in Parkinson’s Disease

    J. Sun, J. Ma, L. Gao, J. Wang, D. Zhang, L. Chen, J. Fang, T. Feng, T. Wu (Beijing, China)

    Objective: We used resting-state functional MRI (rs-fMRI) to investigate the alterations of functional connectivity (FC) of LC-related resting-state networks (RSNs) and the associations between RSNs…
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • 2023 International Congress

    Quantifying the value of multimodal MRI in outcomes prediction for STN DBS in PD

    J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)

    Objective: To compare the predictive value for motor outcomes of multimodal MRI to clinical predictors alone in STN DBS for PD. Background: STN DBS is…
  • 2023 International Congress

    Investigating glutamate toxicity associated to Park2 mutations in pre-clinical models of Parkinson’s Disease

    I. Trezzi, M. Regoni, M. Magni, M. Schröter, A. Buccino, D. Lopez, G. Faustini, L. Murro, F. Biella, E. Frattini, R. Silipigni, M. Passafaro, A. Bellucci, M. Bortolozzi, J. Sassone, A. Di Fonzo (Milan, Italy)

    Objective: To generate and characterize induced pluripotent stem cells (iPSCs)-derived in vitro cellular models of Autosomal Recessive Juvenile Parkinsonism (ARJP) carrying Park2 mutations with a…
  • 2023 International Congress

    Beyond Parkinson´s disease and synucleinopathies: unexpected identification of prodromal corticobasal syndrome by the updated MDS research criteria for prodromal PD

    K. Kulcsarova, E. Feketeova, J. Ventosa, M. Maretta, A. Lackova, M. Ostrozovicova, N. Lesko, M. Bekeová, P. Christová, S. Muranska, S. Mrazova, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of the current study was to determine the proportion of patients, initially classified as having prodromal Parkinson’s disease (pPD), phenoconverted to manifest…
  • « Previous Page
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley